Recombinant Bombyx mori membrane alanyl aminopeptidase (mAAP) refers to the genetically engineered version of the native enzyme, expressed in heterologous systems for detailed characterization. mAAP is a type II integral membrane glycoprotein anchored to the apical brush border membrane of midgut epithelial cells. It catalyzes the removal of N-terminal amino acids from oligopeptides, facilitating nutrient absorption .
Recombinant mAAP is typically produced using:
Baculovirus/Insect Cell Systems: Preserves native glycosylation patterns and membrane localization .
Escherichia coli: Used for non-glycosylated forms to study core enzymatic activity .
Substrate Specificity: Broad activity toward unsubstituted oligopeptides, with preference for alanine residues at the N-terminus .
Enzymatic Activity: Optimal pH range of 7.0–8.5 and temperature stability up to 40°C .
Toxin Interaction: Binds Bacillus thuringiensis (Bt) Cry toxins, implicating mAAP as a receptor in toxin-mediated insect lethality .
Cry1Ac and related Bt toxins interact with mAAP on midgut brush border membranes, disrupting epithelial integrity .
Ligand Binding Assays: Cry toxins show prominent binding to ~110 kDa mAAP isoforms in Bombyx mori .
Bombyx mori expresses multiple mAAP isoforms (e.g., APN1, APN4, APN9) with molecular weights ranging from 88–114 kDa .
Key Isoform Features: